Loading clinical trials...
Loading clinical trials...
Clinical Study to Assess the Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Conditions
Interventions
TA-650 3 mg/kg
TA-650 6 mg/kg
+1 more
Start Date
September 1, 2005
Primary Completion Date
May 1, 2007
Completion Date
May 1, 2007
Last Updated
January 7, 2026
NCT07484243
NCT06647069
NCT06841562
NCT07268326
NCT07233655
NCT07029555
Lead Sponsor
Tanabe Pharma Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions